Evidence map›Paper›PMID 38348228›Full record

ArticleInfection and drug resistance2024

Clinical Characteristics and Drug Resistance Mechanisms of Linezolid-Non-Susceptible

Mengying Wu, Jia Kang, Jia Tao, Yanwen Yang, Gang Li, Wei Jia

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Isolation ofAntibiotics (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mengying WuMedical Experimental Center, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China.
Jia KangMedical Experimental Center, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China.ORCID 0000-0001-9143-1946
Jia TaoMedical Experimental Center, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China.
Yanwen YangDepartment of Neurology, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China.
Gang LiMedical Experimental Center, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China.
Wei JiaMedical Experimental Center, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China.ORCID 0000-0003-4579-891X
Ningxia Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To understand the detection rate and distribution characteristics of Linezolid-nonsusceptible Methods: A total of 40 LNSE strains isolated from clinical specimens between January 1, 2012, and December 31, 2022, were collected. The LNSE isolates identified by instrument detection were confirmed using a microbroth dilution method. The WHONET 5.0 software was used for statistical analysis of LNSE detection rate, and the LNSE judgment was based on the 2022 CLSI criteria. PCR methods were used to detect 23S rRNA, Results: A total of 6924 Conclusion: The detection of LNSE strains was dominated by

Indexed as

linezolid-nonsusceptible EnterococcusMLSToptrAPCRST16

Identifiers

PMID38348228
PMCPMC10860515
OpenAlexW4391648782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.